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ARTICLE
Autosomal Recessive Ichthyosis with Hypotrichosis Caused
by a Mutation in ST14, Encoding Type II Transmembrane Serine
Protease Matriptase
Lina Basel-Vanagaite, Revital Attia, Akemi Ishida-Yamamoto, Limor Rainshtein, Dan Ben Amitai,
Raziel Lurie, Metsada Pasmanik-Chor, Margarita Indelman, Alex Zvulunov, Shirley Saban,
Nurit Magal, Eli Sprecher, and Mordechai Shohat
In this article, we describe a novel autosomal recessive ichthyosis with hypotrichosis syndrome, characterized by con-
genital ichthyosis associated with abnormal hair. Using homozygosity mapping, we mapped the disease locus to 11q24.3-
q25. We screened the ST14 gene, which encodes matriptase, since transplantation of skin from matriptase5/5-knockout
mice onto adult athymic nude mice has been shown elsewhere to result in an ichthyosislike phenotype associated with
almost complete absence of erupted pelage hairs. Mutation analysis revealed a missense mutation, G827R, in the highly
conserved peptidase S1–S6 domain. Marked skin hyperkeratosis due to impaired degradation of the stratum corneum
corneodesmosomes was observed in the affected individuals, which suggests that matriptase plays a signiﬁcant role in
epidermal desquamation.
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Autosomal recessive congenital ichthyoses are clinically
and genetically heterogeneous genodermatoses character-
ized by abnormal epidermal differentiation. They can be
classiﬁed into two groups: (i) primary ichthyoses limited
to the skin and (ii) syndromic ichthyoses, associated with
extracutaneous features.
Six genes are known to be associated with nonsyn-
dromic autosomal recessive congenital ichthyoses: TGM1
(MIM *190195),1,2 ALOXE3 (MIM *607206), ALOX12B
(MIM *603741),3,4 ABCA12 (MIM *607800),5,6 ICHTHYIN
(MIM 609383),7 and FLJ39501.8 In addition, linkage to
chromosomal loci on 12p11.2-q139 and 19p13.1-p13.210
has been reported.
Several autosomal recessive ichthyoses with hair abnor-
malities have been described.11 Netherton syndrome (NTS
[MIM #256500]) is characterized by congenital ichthy-
osiform erythroderma, trichorrhexis invaginata, and atop-
ic manifestations. Mutations in SPINK5, which encodes
LEKTI, an inhibitor of serine proteases, were identiﬁed as
the cause of NTS.12 Congenital ichthyosis, follicular atro-
phoderma, hypotrichosis, and hypohidrosis syndrome
(MIM 602400) is characterized by diffuse congenital ich-
thyosis, patchy follicular atrophoderma, generalized and
diffuse nonscarring hypotrichosis, and marked hypohi-
drosis.13,14 Trichothiodystrophy with congenital ichthyo-
sis—that is, ichthyosis, brittle hair, intellectual impair-
ment, decreased fertility, and short stature (IBIDS [MIM
#601675])—a rare autosomal recessive disorder character-
ized by sulfur-deﬁcient brittle hair and nails, mental re-
tardation, impaired sexual development, and ichthyosis,
is caused by mutations in the ERCC3/XPB15 and ERCC2/
XPD16 genes. Ichthyosis, split hairs, and amino aciduria
syndrome (MIM 242550) is characterized by lamellar ich-
thyosis, splitting of the hair shaft, amino aciduria, and
mental retardation.17
In this study, we describe a novel autosomal recessive
ichthyosis with hypotrichosis syndrome (ARIH) character-
ized by congenital ichthyosis associated with abnormal
hair. We report on the identiﬁcation of the disease-causing
mutation in the ST14 gene that encodes the serine pro-
tease matriptase.
Subjects and Methods
Patients
We ascertained a consanguineous Israeli-Arab family with ARIH,
including three affected and ﬁve unaffected individuals. All the
patients were siblings and were the offspring of parents who were
ﬁrst cousins.We obtained informed consent from all familymem-
bers or their legal guardians, according to a protocol approved
and reviewed by the National Committee for Genetic Studies,
Israel Ministry of Health, and the Rabin Medical Center.
Homozygosity Mapping and Linkage Analysis
Genomic DNA for genotyping was extracted from leukocytes
from peripheral venous blood in EDTA by standard procedures.18
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Table 1. Primers Used to Amplify the ST14 Gene
Primer
Pair Exon
Primer Sequence
(5′r3′)
Forward Reverse
1 1 GAGGCCACACCCTGAAACTA GTGCCGGGAGTTGTACTTGA
2 1 GGTGATGGTGAGGGCCTTAG GGTCTCACAGGCGTCGTC
3 1 AGCCGGAGAAAGAGGAAGAG ACAGGAAATTCCACCTGTGC
4 1 GACGACGCCTGTGAGACC ACAGGAAATTCCACCTGTGC
5 2 TTCTCCAAGCTGGACCTCAC GGCCAAGAGATCCTCGTGTA
6 3 AGTGATGGGAAGCAGTCAGG GGTCCCCTTTGCAGATCAC
7 4 ATGGGGGTGATCTGCAAAG AGGACCTCCAGCACCATCT
8 5 GTGTCCTGGAGTCGCTCTG GTCTTCTCTCTGGGGCACTG
9 5 GCCCATGTGTCCTGGAGT GGCCAGCACGTAGTCTTCTC
10 6 CAGTGCCCCAGAGAGAAGAC GGCCTGGAAAGATCGTCATA
11 7 AGGCCTGAGGTCCACACC TTGTACACCGTCACCAGGTC
12 7 CTTCCCTGACAGCCCCTAC GCGGCCAAGAGTCATAAACT
13 8 CTGTGGATGGGACCAGAGTT TCTAGCCTGTGGCCTCCTAA
14 9 ACCTGCTGTGCAGCATCC CATCTGCACAGGGAGACACA
15 10 AACAAACACGCTGGGAGAAC CCTCTCTCCGCAGTATCTGG
16 11 GGAGGGGTCCCACCAGAC CAGCAAAGCACGATGCTAAC
17 12 CTGCTCCTGTGTGTTTGTGG GGGCCAGAGGTCTCTACACA
18 13 GGTCCCCAGGTAGCTCTGA CTGGAGAGGCACCAGGACT
19 14 GAGCAGGGGTGCAGTGAGT GTCCTGCATGTGCGTGTG
20 15 GCCATTGGTGGTTTCTGG ACCTCCAGGTGCACCCTCT
21 16 GGTCTCCTGGCACACACTG CCTCGGTGCCAACCTATC
22 17 ATCGTCTTCTCGTAGCAGCA GTACTCTGCCGGTTTCTCCA
23 17 CCACCCCTTCTTCAATGACT GACACGCAGAGGAAACACG
24 18 TCTGGGCTGTTCCAGAGTTT CACACCGGCCTGGAAGAT
25 19 ATGTGCGTGGGCTTCCTC AGTCAGCGGTCCAGTCTCC
26 19 TTCGGGACTGGATCAAAGAG TTAGAGACAGGGGAGGCAGA
27 19 CAAAGTGGAGCTGGGAGGTA CTCAGACCCGTCTGTTTTCC
28 19 CCTCCTCAGTGAAGGTGGTG CTGACTCCAGGGTCTGTGCT
SNP genotyping was performed on Affymetrix Human Mapping
50k Xba 240 arrays. All procedures and methods were performed
according to the manufacturer’s instructions. In brief, for each
sample, 250 ng of genomic DNA were digested usingXbal. Primer
sequences were ligated to the digested fragments, and a single-
primer PCR was performed on a PE9700 thermal cycler (Applied
Biosystems). The PCR products were puriﬁed using Qiagen Min-
Elute 96 UF plates. After puriﬁcation, 40 mg of each ampliﬁed sam-
ple was fragmented, end-labeled, and hybridized to a GeneChip
array. After washing and staining, the arrays were scanned using
the GeneChip scanner 3000 with GeneChip Operating Software
(GTYPE) version 1.4. Array CEL ﬁles were processed with Gene-
Chip DNA Analysis Software version 4.0. For the examined sam-
ples, an average call rate of 195% was obtained.
Microsatellite markers were ampliﬁed by multiplex PCR, with
use of standard protocols. Ampliﬁed markers were electropho-
resed on an ABI 3700 DNA capillary sequencer and were analyzed
with GENESCAN and GENOTYPER software (Applied Biosystems).
For the LOD-score calculation, the two-point linkage analysis for
markers D11S4091, D11S4150, and D11S4131 on 11q24.3 was
performed using the program SUPERLINK.19 We assumed a sus-
ceptibility allele with frequency 0.0001 and a recessive mode of
inheritance with penetrance 0.99. For LOD-score calculations, the
number of alleles was set as the number observed in the pedigree,
rather than the number observed elsewhere, to provide a conser-
vative estimate of the LOD score.
Sequencing of the Candidate Genes
Sequencing of the candidate genes was performed with primer
sets designed using the Primer3 program. All exons—including
exon-intron junctions, 5′ UTRs, and 3′ UTRs—were ampliﬁed from
genomic DNA with primers designed from the genomic sequences
available from the University of California–Santa Cruz (UCSC)
Genome Browser. Both strands of the PCR products were se-
quenced with BigDye Terminators (Applied Biosystems) on anABI
3100 sequencer. Sequence chromatograms were analyzed using
SeqScape software version 1.1 (Applied Biosystems). We initially
tested one affected individual and one heterozygous parent.
Sequencing of the ST14 gene was performed using 28 primer
pairs (table 1). ST14 mutation screening was performed on ge-
nomic DNA by PCR ampliﬁcation with primer A, 5′-ATGTGCGT-
GGGCTTCCTC-3′ (forward), and primer B, 5′-AGTCAGCGGTCC-
AGTCTCC-3′ (reverse), followed by sequencing.
Mutation Detection by Restriction Analysis
Ampliﬁcation of a 379-bp fragment from genomic DNA was per-
formed using primers A and B for 37 cycles at an annealing tem-
perature of 55C. The mutation introduces a BpmI restriction site,
which digests the 379-bp fragment into 215-bp and 164-bp frag-
ments. The fragment was digested with 2 U/mg BpmI (New En-
gland Biolabs), and the reaction products were separated by elec-
trophoresis on 3% NuSieve/1% agarose gels.
Bioinformatics Methods
The gene and the protein were described using theUCSCGenome
Browser (March 2006 assembly), the Ensembl Genome Browser
(June 2006 assembly), and bioinformatics servers. To analyze con-
servation of the variation site, 10 vertebrate (from ﬁsh to human)
sequence homologues to the human ST14 protein were collected
using BLink (“BLAST Link”). Comparative sequence analysis (mul-
tiple sequence analysis [MSA]) was performed by ClustalW with
a Java viewer (Clustal Alignment), as described by Higgins et al.20
and Clamp et al.21 The ConSeq Server was used to validate se-
quence conservation and to predict functionality.22 The SIFT
server sorts intolerant from tolerant amino acid substitutions and
predicts phenotypic variations, as described byNg andHenikoff.23
Human ST14 protein was used as the input for SIFT analysis.
Immunohistochemistry
Formaldehyde-ﬁxed 5-mmparafﬁn-embedded sections were treated
with 3% H2O2 in methanol for 15 min at room temperature, were
warmed in a microwave oven in citrate buffer for 15 min at
90C, and were stained with antibodies directed against ﬁlaggrin
(Novocastra), loricrin (Covance Research Products), involucrin
(Covance Research Products), and cytokeratin 1 (BioGenex) or
against preimmune rabbit antiserum for 1 h at room temperature.
After extensive washings in PBS, the antibodies were revealed
using the ABC technique (Zymed Laboratories), and the slides
were counterstained using hematoxylin.
Electron Microscopy and Immunoelectron Microscopy
Postembedding electron microscopy with Lowicryl HM20 resin
was performed as described elsewhere.24 For immunoelectronmi-
croscopy, ultrathin sections were incubatedwith antibodies against
LEKTI (Zymed Laboratories) and corneodesmosin (CDSN).25
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Figure 1. Clinical features of the patients. A and B, Hair of patients III-1 and III-8, respectively. Sparse and curly hair is observed.
C and D, Ichthyotic skin of patient III-1 on the trunk and of patient III-5 on the upper limb, respectively.
Figure 2. Light microscopy (A–C) and SEM (D–F) examination of hair obtained from affected patients. A and B, Dysplastic hair. Hair
shafts are irregular, ﬂaky, and undulating (A). B, Magniﬁed undulation of panel A. C, Pili torti. Affected shaft is twisted on its own
axis. D and E, Pili bifurcati. Each bifurcation produces two separate parallel branches that fuse again to form a single shaft; each branch
is covered with its own cuticle. F, Central pili mono bifurcati: bifurcation that does not fuse again to the hair shaft and is located in
the middle of the hair shaft. A minimum of 50 hairs from each patient were examined.
Results
Clinical and Laboratory Evaluation
The patients were all born, after full-term, normal preg-
nancies, with normal birth weights. There was no collo-
dion membrane. Ichthyosis and abnormal hair were pre-
sent at birth. Patients III-5 and III-8 had a vernixlike layer
covering the entire body, which was progressively shed
during the ﬁrst month of life. Hypotrichosis was gener-
alized and diffuse (ﬁg. 1A and 1B). Scaling was diffuse,
including on the scalp, but the face was unaffected (ﬁg.
1A, 1C, and 1D). Clinically, the hair of all the patients
appeared curly, sparse, fragile, brittle, dry, and lusterless
and showed slow growth. Light microscopy and scanning
electron microscopy (SEM) examination of hair obtained
from affected patients disclosed a number of abnormali-
ties, including dysplastic hair (ﬁg. 2A and 2B), pili torti
(ﬁg. 2C), pili bifurcati (ﬁg. 2D and 2E), and central pili
mono bifurcati (ﬁg. 2F). Over time, scalp hair growth and
appearance improved, and the scalp hair darkened with
age. All three affected individuals had photophobia, and
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Table 2. Clinical Characteristics of the Patients
Patient
Characteristic III-1 III-5 III-8
Age (in years) 17 8 2.5
Skin:
Abnormalities at birth Scaling Vernixlike Vernixlike
Color Gray Gray and brown Gray and brown
Hair:
Scalp hair Dark brown Uneven length, light brown Uneven length, light brown
Eyebrows Sparse and curly Sparse, more lateral parts, light colored Sparse, more lateral parts, light colored
Body hair Sparse Sparse Sparse
Eyes:
Corneal abnormality No No Corneal opacity
Photophobia Yes Yes Yes
Other Pingueculum from age 11 years
Other:
Teeth Normal Notching, pitting Conical primary teeth
Infections No Chronic sinusitis No
Itching Yes Yes Yes
NOTE.—All patients had skin abnormalities of the scalp, neck, abdomen, back, and limbs (extensor surfaces) and had long, curly, dark upper
eyelashes and curly, sparse, fragile, brittle, dry, lusterless scalp hair, with receding frontal hairline.
one had corneal opacities. The clinical features of the pa-
tients are summarized in table 2.
Follicular atrophoderma, palmoplantar keratoderma,
and hyperlinearity were not seen. The nails and mucosa
were normal. No erythroderma, cardiac abnormalities, dig-
ital contractures, loss of pulp volume, ectropion, or hypo-
plasia of the nasal/auricular cartilage was observed. Sweat-
ing was normal, and there were no episodes of hyperna-
tremic dehydration or hyperthermia. There were no atopic
manifestations or photosensitivity. Complete blood count,
urea, creatinine, liver enzymes, T-cell count, and immuno-
globulins IgG, IgM, IgA, and IgE were all normal.
Patients III-2, III-3, III-6, and III-8 also have Hirsch-
sprung disease, which is unrelated to the ichthyosis. Pa-
tient III-2 died at age 2.5 years from gastrointestinal com-
plications of severe Hirschsprung disease (total colonic
aganglionosis).
ARIH Mapping on 11q24.3-q25
A visual inspection of the SNP data showed that all the
patients exhibited a large continuous segment of homo-
zygosity for 53 consecutive SNPs, encompassing 5 Mb be-
tween markers rs3926407 and rs576825 on 11q24.3-q25
(table 3 and our tab-delimited txt ﬁle [online only]). These
data were supportive of homozygosity by descent. Other,
smaller genomic regions showing homozygosity in con-
secutive SNPs in all the patients on chromosomes 2, 5, 8,
9, 13, 14, and 17 were excluded by genotyping microsat-
ellite markers D2S2375, D2S2360, D5S1384, D5S1505,
D8S549, D8S1731, D9S52, D9S104, D9S43, D9S251,
D13S286, D13S1311, D13S173, D13S1265, D13S801,
D14S592, D14S1429, D17S947, D17S917, and D17S808 in
all nine family members (data not shown). Linkage to the
locus on chromosome 11q24.3-q25 was conﬁrmed by ge-
notyping microsatellite markers D11S4091, D11S4150, and
D11S4131 in all nine family members (ﬁg. 3A). LOD-score
analysis for the marker D11S4150 yielded a Zmax score of
2.21 at recombination fraction (v) 0.00 (table 4). A higher
LOD score could not be obtained because of the small
family size. The candidate region contains 22 known or
predicted genes (ﬁg. 3B).
Mutation Analysis
All exons—including promoter region, exon-intron junc-
tions, and 5′ and 3′ UTRs—of the BARX2 gene were se-
quenced, and no pathogenic sequence changeswere found.
BARX2-knockout mice display short hair.26
Sequencing of the ST14 gene revealed missense muta-
tion c.2672GrA in exon 19 (according to “Recommenda-
tions for the Description of DNA Sequence Variants” [En-
sembl Genome Browser]) (ﬁg. 3C). The mutation causes a
glycinerarginine change at residue 827 (G827R) of the
protein, in the peptidase S1–S6 domain.
The ST14 mutation segregated with the disease; affected
patients displayed homozygous mutations, whereas par-
ents displayed heterozygosity for a normal and a disease
allele, consistent with autosomal recessive inheritance (ﬁg.
3A). The mutation was not observed in 434 chromosomes
from unrelated control individuals of Arab origin.
MSA was performed using 10 protein-sequence homo-
logues for human ST14, including vertebrates from ﬁsh to
human. A highly conserved region is present at the C-
terminal region of the protein, harboring the Tryp_SPc
(trypsinlike serine protease) domain, which includes the
G827 residue of the human protein (ﬁg. 4A). The ConSeq
Server was used to further support these data. The pep-
tidase C-terminal domain is shown (ﬁg. 4B). Predicted re-
sults for residue G827 in the human protein showed that
no change in this amino acid is tolerated (results not
shown). Structural analysis of matriptase (1EAW in the
Protein Data Bank) showed that the G827 variation is only
two residues away from an important catalytic residue
(serine 825).
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Table 3. Homozygosity for SNP Markers on
11q24.2-q25
Chromosome
and Location SNP
Genotype for Patient
III-1 III-5 III-8
11q24.2:
126135641 rs2226935 BB BB BB
126153350 rs1946052 AA AA AA
126259661 rs1940007 BB BB BB
126259725 rs1940006 AA AA AA
126314224 rs1939990 AA AA AA
126314287 rs1939991 BB BB BB
126314915 rs1939992 AA AA AA
126357648 rs631562 AA AA AA
126369604 rs488054 BB BB BB
126369798 rs541783 BB BB BB
126397423 rs1944627 AA AA AA
126401733 rs642387 AA AA AA
126402187 rs503397 BB BB BB
126553569 rs1944828 BB BB BB
126553743 rs1944827 BB BB BB
126861051 rs749514 AA AA AA
126861482 rs1729076 AA AA AA
126936044 rs356248 BB BB BB
126944448 rs356262 BB BB BB
126971973 rs763300 BB BB BB
127004821 rs10490847 BB BB BB
127004961 rs7928097 AA AA AA
11q24.3:
127344152 rs1364780 AA AA AA
127525578 rs1477577 AA AA AA
127562693 rs476994 AA AA AA
127584911 rs1940356 AA AA AA
127585108 rs1940357 BB BB BB
127653338 rs510628 AA AA AA
127654275 rs722345 BB BB BB
127774235 rs2323123 BB BB BB
127920339 rs4128561 AA AA AA
127921152 rs4129229 BB BB BB
128134145 rs631647 AA AA AA
128134871 rs670809 BB BB BB
128416643 rs2155177 BB BB BB
128466905 rs657820 BB BB BB
128624506 rs4129583 BB BB BB
128904021 rs2008849 AA AA AA
128983138 rs2172487 BB BB BB
128984385 rs1873873 BB BB BB
129012244 rs952131 BB BB BB
129513314 rs879780 BB BB BB
129860441 rs3898490 BB BB BB
11q25:
129879261 rs1272496 BB BB BB
130306606 rs1893225 AA AA AA
130679085 rs1793584 BB BB BB
130680535 rs1114296 BB BB BB
130697593 rs1793783 BB BB BB
130729658 rs4128590 BB BB BB
130729798 rs4128594 AA AA AA
130853281 rs1355982 BB BB BB
130897898 rs411280 AA AA AA
131091392 rs796873 AA AA AA
NOTE.—SNPs are shown on the dbSNP Web site.
Consequences of G827R in ST14
Marked acanthosis and a much thickened stratum cor-
neum were demonstrated in affected skin by light mi-
croscopy (ﬁg. 5). Since it has been suggested that proteases
in general and matriptase in particular play an important
role in the formation of the epidermal barrier,27 we com-
pared the expression of a number of elements of the cor-
niﬁed cell envelope in skin-biopsy samples obtained from
patients and healthy control individuals. No signiﬁcant
differences were noticed in the intensity or pattern of ex-
pression of ﬁlaggrin, loricrin, involucrin, and keratin 1 be-
tween unaffected and affected skin (ﬁg. 5).
We then examined the ultrastructural consequences of
the G827R mutation in the ST14 gene. We ﬁrst examined
the granular layers of the epidermis from a patient. La-
mellar granules and keratohyaline granules displayed nor-
mal features. Immunoelectron microscopic examination
of the skin-biopsy samples of a patient revealed normal
distribution of LEKTI and CDSN (ﬁg. 6).
The most remarkable and consistent abnormal ﬁnding
was the conspicuous presence of intact corneodesmosomes
in the upper corniﬁed layers of affected epidermis, in con-
trast with the normal degradation of these structures in
control skin (ﬁg. 7). This ﬁnding suggests a major physio-
logical role for matriptase during epidermal desquamation.
Discussion
In this study, we describe a novel autosomal recessive ich-
thyosis syndrome featuring both ichthyosis and abnormal
hair distribution and structure, which we have named
“autosomal recessive ichthyosis with hypotrichosis syn-
drome.” This disorder is clinically distinct from other geno-
dermatoses involving skin and hair abnormalities. Com-
pared with subjects affected with NTS, our patients have
a milder disease, no erythrodermatous skin changes, no
atopic manifestations, and no increased IgE. Congenital
ichthyosis, follicular atrophoderma, hypotrichosis, and hy-
pohidrosis syndrome is distinguished by the presence of
hypohydrosis and follicular atrophoderma, which were
not observed in our family. The ichthyosis, split hairs, and
amino aciduria syndrome is characterized by mental re-
tardation, whereas our patients have intact cognition.
Mental retardation, brittle nails, and impaired sexual de-
velopment are present in trichothiodystrophy with con-
genital ichthyosis syndrome (Tay or IBIDS syndrome);
these were absent in our patients. The syndrome of ich-
thyosis follicularis with atrichia and photophobia (IFAP
syndrome [MIM %308205]) is characterized by severe fol-
licular hyperkeratosis, complete baldness, and photopho-
bia; however, our patients have no atrichia or ichthyosis
follicularis. Most importantly, IFAP syndrome is consid-
ered an X-linked condition.28
We have demonstrated that this new syndrome (i.e.,
ARIH) is caused by a mutation in ST14 that encodes ma-
triptase, a type II transmembrane serine protease of the
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Table 4. Two-Point LOD Scores for Chromosome 11q24
Markers
Locus
LOD at v p
.00 .01 .05 .10 .20 .30 .40
D11S4091 2.0047 1.9569 1.7651 1.5245 1.0425 .5725 .1736
D11S4150 2.2122 2.1657 1.9776 1.7382 1.2481 .7525 .2912
D11S4131  .1701 .6990 .7853 .6568 .4177 .1692
Figure 3. Family tree, candidate region, and mutation analysis. A, Pedigree of the family and segregation analysis of the mutation.
Segregation was assayed by PCR ampliﬁcation of the genomic DNA and restriction by BpmI. The wild-type allele is uncut. Blackened
symbols represent affected individuals. An arrow shows informative recombination. B, Candidate region. C, Mutation analysis of ST14.
Sequence chromatogram from wild-type (WT), carrier (C), and affected (M) genotypes on genomic DNA.
S1 trypsinlike family.29 Taking into account strict protease
domain conservation and residue-change properties, in
addition to its critical location near an important catalytic
residue (serine 825), we predict that the amino acid change
G827R leads to a severe change in protein function. This
protein contains an N-terminal transmembrane domain,
two tandem repeats of a CUB (C1r/s, Uegf and bone mor-
phogenetic protein-1) domain, four tandem repeats of a
low-density lipoprotein receptor domain, and a conserved
extracellular serine protease catalytic domain.30Matriptase
is expressed predominately in the epithelial cells of the
surface-lining epithelium.31 In the interfollicular epider-
mis, matriptase expression is restricted to the postmitotic
transitional layer of keratinocytes undergoing terminal
differentiation.32 Similar to some other members of the
type II transmembrane serine-protease group, matriptase
exists in a soluble and membrane-bound form.33,34 The
activation of matriptase requires proteolytic cleavage that
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Figure 4. Multiple alignment and conservation analysis of human ST14 with its orthologues. A, Multiple sequence alignment, performed
by ClustalW (Clustal Alignment), with use of 10 protein sequences of matriptase, including vertebrates from ﬁsh to human: Homo sapiens
(human) ST14, (GenBank accession number NP_068813), Homo sapiens (human) prostamin (GenBank accession number BAB20376),
Homo sapiens (human) serine protease (GenBank accession number AAG15395), Pan troglodytes (chimpanzee) homologue (GenBank
accession number XP_508863), Mus musculus (mouse) matriptase (GenBank accession number BAE38987), Rattus norvegicus (rat)
matriptase (GenBank accession number AAH97271), Gallus gallus (chicken) matriptase (GenBank accession number XP_417872), Canis
familiaris(dog) matriptase (GenBank accession number XP_546396), Xenopus laevis (frog) matriptase (GenBank accession number
AAH71077), and Danio rerio (zebraﬁsh) hypothetical protein (GenBank accession number NP_001035441). G827 is marked with an arrow.
Residue colors represent amino acid biochemical properties according to Zappo colors. Conservation scale is shown below the alignment
(yellow bars). B, Sequence conservation analysis, performed using the ConSeq Server, with internal MSA alignment serving as input.
Residue G827 is circled in red. Conserved regions are marked with dark magenta, and variable regions are marked with green. Exposed
(e) and functional (f) residues can be seen.
converts the enzyme from a one-chain zymogen to an
active two-chain protease.35
Several proteases and their inhibitors—such as cathep-
sin L, cathepsin D, cathepsin C, cystatin M/E, the stratum
corneum chymotryptic enzyme (KLK7), the stratum cor-
neum tryptic enzyme (KLK5), and LEKTI—are important
in epidermal homeostasis and/or hair follicle formation.36,
37 Two serine proteases of the kallikrein family—KLK7 and
KLK5—have been implicated in the degradation of cor-
neodesmosomal proteins in the epidermis.37
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Figure 5. Corniﬁed cell envelope–protein expression (original
magniﬁcation #400). Skin-biopsy sections obtained from a con-
trol individual (A, C, E, and G) and a patient (B, D, F, and H) were
stained with antibodies directed against ﬁlaggrin (A and B), lor-
icrin (C and D), involucrin (E and F), and keratin 1 (G and H) and
were examined by light microscopy. Note the marked acanthosis
(H) and thickened stratum corneum (indicated by an asterisk [*]
in panel D) in affected skin.
Figure 6. Normal-looking lamellar granules with immunoreactiv-
ity to LEKTI and CDSN in the skin of a patient. Skin-biopsy samples
from a patient were examined by electron microscopy. The top
panel is an unlabeled Lowicryl HM20-embedded section stained
with uranyl acetate and lead citrate, showing laminated internal
structures within lamellar granules (arrowheads). The lower panels
are 5-nm immunogold-labeled (arrows) sections with antibodies
against LEKTI and CDSN.
The present study suggests that matriptase may also be
involved in the desquamation process, since degradation
of corneodesmosomes in ARIH is impaired. The lack of
inhibition of KLK7 and KLK5 by the serine-protease in-
hibitor LEKTI may be related to the phenotypic manifes-
tations of NTS.38 In NTS, corneodesmosome degradation
is accelerated,25 suggesting that matriptase may be an ad-
ditional substrate for LEKTI. Interestingly, similar to ARIH,
the persistence of corneodesmosomes in the stratum cor-
neum was observed in autosomal dominant ichthyosis
vulgaris and X-linked ichthyosis.39
No human diseases associated with mutations in the
ST14 gene have been described elsewhere, although ma-
triptase overexpression has been implicated in cancer me-
tastasis.40 Matriptase/-knockout mice have been gener-
ated27,41; these mice die shortly after birth as a result of
deﬁcient epidermal-barrier function in the skin in new-
borns. They also demonstrate abnormal hair-follicle de-
velopment and disturbed thymic homeostasis that results
in increased lymphocyte apoptosis in the thymus of the
newborn mice.41 Our patients did not display any signs
suggestive of a T cell–related immunological defect. In-
terestingly, 3 wk after transplantation of whole skin from
matriptase/ mice to adult athymic nude mice, the skin
from the knockout mice showed severe epidermal thick-
ening, the formation of ichthyosislike epidermal scales,
and almost complete absence of erupted pelage hairs.42
Therefore, systemic expression of matriptase does not cor-
rect the epidermal defects in matriptase-deﬁcient skin.
The relatively mild manifestations of ARIH syndrome
contrast with the severe phenotype of knockoutmice. This
may be because the identiﬁed missense mutation has a
milder effect as compared with total protein deﬁciency in
the knockout mice.
It has been shown that, in mice, matriptase deﬁciency
correlates with abnormal proteolytic processing of the epi-
dermal protein proﬁlaggrin into ﬁlaggrin monomer units
and the NH2-terminal ﬁlaggrin S-100 regulatory protein,
resulting in accumulation of proﬁlaggrin and aberrant pro-
ﬁlaggrin-processing products in the stratum corneum.42
Although we were unable to directly assess ﬁlaggrin pro-
cessing, the distribution of this protein in the epidermis
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Figure 7. Impaired degradation of corneodesmosomes in affected
skin. Skin-biopsy samples from a patient (left panels) and a healthy
individual (right panels) were examined by electron microscopy.
Stratum corneum is greatly thickened in the patient’s skin com-
pared with that of the control individual (top panels, with the
same magniﬁcation). The rectangular areas marked in the top pan-
els are shown at higher magniﬁcations in the middle panels. Cor-
neodesmosomes are intact in the upper layer, with many CDSN
labels (arrows) in the patient (left, middle), whereas they are de-
graded with only a few CDSN labels remaining in the upper stratum
corneum in normal skin (right, middle). The lower panels show
desmosomes between the uppermost stratum granulosum (G) and
the ﬁrst corniﬁed cells positively labeled with CDSN in both patient
and control skin.
was normal. Ultrastructural analysis of the granular layer
of neonatal matriptase/ epidermis showed sparse and dis-
organized lamellar bodies. In our patients, lamellar gran-
ules were found to be morphologically normal.
All the patients showed various hair abnormalities, in-
cluding dysplastic hair, pili torti, pili bifurcati, and central
pili mono bifurcati. Interestingly, multiple hair abnormal-
ities—including trichorrhexis invaginata, pili torti, trichor-
rhexis nodosa, and helical hairs—have been reported in
NTS.43,44
In conclusion, we have shown that a mutation in ST14
encoding the type II transmembrane serine protease ma-
triptase causes a novel autosomal recessive genodermato-
sis characterized by ichthyosis and abnormal hair. The fact
that the patients show abnormal degradation of corneo-
desmosmes in the upper layers of the stratum corneum
suggests a role of this protease in epidermal desquamation,
possibly via impaired proteolytic degradation of corneo-
desmosomal proteins.
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